nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurandrenolide—Drospirenone—PTGS2—head and neck cancer	0.397	0.397	CrCbGaD
Flurandrenolide—Betamethasone—PTGS2—head and neck cancer	0.24	0.24	CrCbGaD
Flurandrenolide—Dexamethasone—CYP1A1—head and neck cancer	0.224	0.224	CrCbGaD
Flurandrenolide—Dexamethasone—PTGS2—head and neck cancer	0.14	0.14	CrCbGaD
